AP – U.S. regulators have refused to accept drugmaker Merck & Co.’s application for a new, combination cholesterol pill that includes rival Pfizer’s Lipitor, the world’s top-selling drug.
View original post here:
FDA won’t accept Merck’s application for new drug
(AP)
Similar Posts:
- Abbott, AstraZeneca seek cholesterol pill approval
(AP) - Merck’s heart failure drug misses trial goals
(AP) - AstraZeneca, Merck collaborate on cancer treatment
(AP) - Merck: It's Not All Crystal Clear – Forbes
- Once-a-day heart combo pill shows promise in study
(AP) - CORRECT: =Merck 1Q Net Down 56% Amid Yr-Ago Gain, Sales Drop – Wall Street Journal
FDA won’t accept Merck’s application for new drug (AP)
If you enjoyed this post, make sure you subscribe to my RSS feed!
Leave a comment